NASDAQ: MEVO
M Evo Global Acquisition Corp IICIK 0002087361 · SIC 6770 · Blank Checks
Small by assets
Assets $305M
as of Oct 4, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (TLRY 10-Q) is open in full — no account needed.
8-K
Filed Oct 13, 2026
· Period ending Oct 6, 2026
Summary not yet generated.
8-K
Filed Sep 11, 2026
· Period ending Sep 9, 2026
Summary not yet generated.
Partner
Trade MEVO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
10-Q
Filed Aug 12, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
10-Q
Filed May 8, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
8-K
Filed Feb 18, 2026
· Period ending Feb 18, 2026
Summary not yet generated.
8-K
Filed Feb 6, 2026
· Period ending Feb 2, 2026
Summary not yet generated.
424B4
Filed Feb 2, 2026
Summary not yet generated.
S-1/A
Filed Jan 26, 2026
Summary not yet generated.
S-1/A
Filed Jan 26, 2026
Summary not yet generated.
S-1
Filed Dec 15, 2025
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 12, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Six months ended June 30, 2026 |
|---|---|---|
| General and administrative costs | 104,267 | 293,488 |
| Compensation expense | — | 8,469,916 |
| Loss from operations | (104,267) | (8,763,404) |
| Other income: | ||
| Interest earned on investments held in Trust Account | 2,670,170 | 4,335,691 |
| Net income (loss) | 2,565,903 | (4,427,713) |
| Basic and diluted weighted average Class A ordinary shares outstanding | 30,000,000 | 24,530,387 |
| Basic and diluted net income (loss) per Class A ordinary share | 0.06 | (0.13) |
| Basic weighted average Class B ordinary shares outstanding (1)(2) | 10,000,000 | 9,817,680 |
| Basic net income (loss) per Class B ordinary share | 0.06 | (0.13) |
| Diluted weighted average Class B ordinary shares outstanding (1)(2) | 10,000,000 | 10,000,000 |
| Diluted net income (loss) per Class B ordinary share | 0.06 | (0.13) |
Condensed Balance Sheets
| Description | June 30, 2026 (unaudited) | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | 947,796 | — |
| Due from Sponsor | 9,154 | — |
| Prepaid expense | 54,829 | 30,260 |
| Prepaid insurance | 70,801 | — |
| Total Current Assets | 1,082,580 | 30,260 |
| Deferred offering costs | — | 213,407 |
| Prepaid insurance long-term | 40,710 | — |
| Investments held in Trust Account | 304,335,691 | — |
| TOTAL ASSETS | 305,458,981 | 243,667 |
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | ||
| Current liabilities | ||
| Accrued expenses | 25,674 | — |
| Accrued offering costs | 78,250 | 37,690 |
| Promissory note related party | — | 230,919 |
| Total Current Liabilities | 103,924 | 268,609 |
| Deferred underwriting fee payable | 12,000,000 | — |
| Total Liabilities | 12,103,924 | 268,609 |
| Commitments and Contingencies (Note 7) | ||
| Class A ordinary shares subject to possible redemption, 30,000,000 shares at a redemption value of $10.14 per share as of June 30, 2026 and no shares as of December 31, 2025 | 304,335,691 | — |
| Shareholders’ Deficit | ||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of June 30, 2026 and December 31, 2025 | — | — |
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued or outstanding (excluding 30,000,000 shares subject to possible redemption) as of June 30, 2026 and December 31, 2025 | — | — |
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 10,000,000 issued and outstanding as of June 30, 2026 and December 31, 2025(1)(2) | 1,000 | 1,000 |
| Additional paid-in capital | — | 24,000 |
| Accumulated deficit | (10,981,634) | (49,942) |
| Total Shareholders’ Deficit | (10,980,634) | (24,942) |
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | 305,458,981 | 243,667 |
Condensed Statement of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 |
|---|---|
| Net loss | (4,427,713) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Payment of general and administrative costs through advances from related party | 10,498 |
| Payment of general and administrative costs through promissory note related party | 51,725 |
| Interest earned on investments held in Trust Account | (4,335,691) |
| Compensation expense | 8,469,916 |
| Changes in operating assets and liabilities: | |
| Prepaid expense | (6,728) |
| Prepaid insurance long-term | 30,091 |
| Due from Sponsor | (8,402) |
| Accrued expenses | 25,675 |
| Net cash used in operating activities | (190,629) |
| Cash Flows from Investing Activities: | |
| Investment of cash into Trust Account | (300,000,000) |
| Net cash used in investing activities | (300,000,000) |
| Cash Flows from Financing Activities: | |
| Proceeds from sale of Units, net of underwriting discounts paid | 294,000,000 |
| Underwriters’ reimbursement | 900,000 |
| Proceeds from sale of Private Placement Warrants | 8,000,000 |
| Repayment of advances from related party | (407,494) |
| Repayment of promissory note related party | (300,000) |
| Payment of offering costs | (1,054,081) |
| Net cash provided by financing activities | 301,138,425 |
| Net Change in Cash | 947,796 |
| Cash and cash equivalents Beginning of period | — |
| Cash and cash equivalents End of period | 947,796 |
| NonCash investing and financing activities: | |
| Offering costs included in accrued offering costs | 78,250 |
| Deferred offering costs paid through promissory note related party | 17,356 |
| Deferred offering costs paid by advances from Sponsor | 196,352 |
| Prepaid expenses paid by advances from Sponsor | 20,600 |
| Prepaid insurance paid by advances from Sponsor | 141,602 |
| Prepaid expenses applied to deferred offering costs | 2,759 |
| Advances to Sponsor paid through promissory note related party | 752 |
| Deferred underwriting fee payable | 12,000,000 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗